Geetha P. Bansal

Array ( [id] => 4081614 [patent_doc_number] => 06017544 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-25 [patent_title] => 'Composition comprising immunogenic stress protein-peptide complexes against cancer and a cytokine' [patent_app_type] => 1 [patent_app_number] => 9/061365 [patent_app_country] => US [patent_app_date] => 1998-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7087 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/017/06017544.pdf [firstpage_image] =>[orig_patent_app_number] => 061365 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4407310 [patent_doc_number] => 06228603 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-08 [patent_title] => 'Screening assays for agents that alter inhibitor of apoptosis (IAP) protein regulation of caspase activity' [patent_app_type] => 1 [patent_app_number] => 9/058969 [patent_app_country] => US [patent_app_date] => 1998-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 18 [patent_no_of_words] => 18930 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/228/06228603.pdf [firstpage_image] =>[orig_patent_app_number] => 058969 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1440811 [patent_doc_number] => 06335163 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-01 [patent_title] => 'Polyclonal antibody libraries' [patent_app_type] => B1 [patent_app_number] => 09/057937 [patent_app_country] => US [patent_app_date] => 1998-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 21 [patent_no_of_words] => 21516 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/335/06335163.pdf [firstpage_image] =>[orig_patent_app_number] => 09057937 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4305439 [patent_doc_number] => 06316007 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-13 [patent_title] => 'Combined physical and immunotherapy for cancer' [patent_app_type] => 1 [patent_app_number] => 9/044365 [patent_app_country] => US [patent_app_date] => 1998-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10668 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/316/06316007.pdf [firstpage_image] =>[orig_patent_app_number] => 044365 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4229258 [patent_doc_number] => 06165464 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-26 [patent_title] => 'Monoclonal antibodies directed to the HER2 receptor' [patent_app_type] => 1 [patent_app_number] => 9/044197 [patent_app_country] => US [patent_app_date] => 1998-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 11 [patent_no_of_words] => 10686 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/165/06165464.pdf [firstpage_image] =>[orig_patent_app_number] => 044197 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4320311 [patent_doc_number] => 06328967 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-11 [patent_title] => 'Delivery system to modulate immune response' [patent_app_type] => 1 [patent_app_number] => 9/041514 [patent_app_country] => US [patent_app_date] => 1998-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 8 [patent_no_of_words] => 7351 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/328/06328967.pdf [firstpage_image] =>[orig_patent_app_number] => 041514 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3915240 [patent_doc_number] => 06001975 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-14 [patent_title] => 'Precursor processed to at least one tumor rejection antigen presented by HLA-A2' [patent_app_type] => 1 [patent_app_number] => 9/033881 [patent_app_country] => US [patent_app_date] => 1998-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 10 [patent_no_of_words] => 4434 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/001/06001975.pdf [firstpage_image] =>[orig_patent_app_number] => 033881 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4097042 [patent_doc_number] => 06099838 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-08 [patent_title] => 'Pharmaceutical compositions comprising anti-CD45RB antibodies for the inhibition of T-cell mediated immune responses' [patent_app_type] => 1 [patent_app_number] => 9/018282 [patent_app_country] => US [patent_app_date] => 1998-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 21 [patent_no_of_words] => 10034 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/099/06099838.pdf [firstpage_image] =>[orig_patent_app_number] => 018282 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4297618 [patent_doc_number] => 06187307 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-13 [patent_title] => 'Cancer immunotherapy with semi-allogeneic cells' [patent_app_type] => 1 [patent_app_number] => 9/016528 [patent_app_country] => US [patent_app_date] => 1998-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 42 [patent_no_of_words] => 20207 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/187/06187307.pdf [firstpage_image] =>[orig_patent_app_number] => 016528 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4177766 [patent_doc_number] => 06159467 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-12 [patent_title] => 'In vivo suppression of osteosarcoma pulmonary metastasis with intravenous osteocalcin promoter-based toxic gene therapy' [patent_app_type] => 1 [patent_app_number] => 9/010114 [patent_app_country] => US [patent_app_date] => 1998-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 11 [patent_no_of_words] => 6159 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/159/06159467.pdf [firstpage_image] =>[orig_patent_app_number] => 010114 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4151359 [patent_doc_number] => 06156321 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-05 [patent_title] => 'Tissue factor methods and compositions for coagulation and tumor treatment' [patent_app_type] => 1 [patent_app_number] => 9/009822 [patent_app_country] => US [patent_app_date] => 1998-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 25 [patent_no_of_words] => 68726 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/156/06156321.pdf [firstpage_image] =>[orig_patent_app_number] => 009822 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4081366 [patent_doc_number] => 06132730 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-17 [patent_title] => 'Combined tissue factor and factor VIIa methods and compositions for coagulation and tumor treatment' [patent_app_type] => 1 [patent_app_number] => 9/009656 [patent_app_country] => US [patent_app_date] => 1998-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 25 [patent_no_of_words] => 68772 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/132/06132730.pdf [firstpage_image] =>[orig_patent_app_number] => 009656 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4081347 [patent_doc_number] => 06132729 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-17 [patent_title] => 'Combined tissue factor and chemotherapeutic methods and compositions for coagulation and tumor treatment' [patent_app_type] => 1 [patent_app_number] => 9/009217 [patent_app_country] => US [patent_app_date] => 1998-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 25 [patent_no_of_words] => 68733 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/132/06132729.pdf [firstpage_image] =>[orig_patent_app_number] => 009217 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1433172 [patent_doc_number] => 06340461 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-22 [patent_title] => 'Superantigen based methods and compositions for treatment of diseases' [patent_app_type] => B1 [patent_app_number] => 08/992877 [patent_app_country] => US [patent_app_date] => 1997-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 55935 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/340/06340461.pdf [firstpage_image] =>[orig_patent_app_number] => 08992877 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4099022 [patent_doc_number] => 06066475 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-23 [patent_title] => 'Parathyroid cytosolic autoantigens recognized by autoantibodies from patients with acquired hypoparathyroidism' [patent_app_type] => 1 [patent_app_number] => 8/991922 [patent_app_country] => US [patent_app_date] => 1997-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9908 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/066/06066475.pdf [firstpage_image] =>[orig_patent_app_number] => 991922 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3977659 [patent_doc_number] => 05948646 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-07 [patent_title] => 'Methods for preparation of vaccines against cancer comprising heat shock protein-peptide complexes' [patent_app_type] => 1 [patent_app_number] => 8/988878 [patent_app_country] => US [patent_app_date] => 1997-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 17944 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/948/05948646.pdf [firstpage_image] =>[orig_patent_app_number] => 988878 [rel_patent_id] =>[rel_patent_doc_number] =>)